Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 6.029\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) C=CCN1C(=O)C(O)(CC(=O)c2ccc(-n3cccc3)cc2)c2ccccc21
(b) CCN1CC(CN(C)Cc2nc(Cc3ccccc3)no2)CC1=O
(c) O=C(C1CCCO1)N1CCN(C(=S)Nc2cc(F)cc(F)c2)CC1
(d) Brc1ccc(C2=Nc3cccc4cccc(c34)N2)o1
(e) CSCC[C@H](NC(=O)Cc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
Answer: e. CSCC[C@H](NC(=O)Cc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCC[C@H](NC(=O)Cc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
CSCC[C@H](NC(=O)Cc1ccc(Cl)cc1)C(=O)N1CCC2(CC1)NCCc1[nH]cnc12
2-(4-chlorophenyl)-N-[(2S)-4-methylsulfanyl-1-oxo-1-spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,4'-piperidine]-1'-ylbutan-2-yl]acetamide